Dashboard
Manage Tickers

RSLS ReShape Weightloss Inc.

Nasdaq www.enteromedics.com


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 5.25
-- x --
-- x --
-- - --
$ 0.03 - $ 14.25
171
na
36.01M
$ 9.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-17-2021 03-31-2021 10-Q
2 03-11-2021 12-31-2020 10-K
3 11-13-2020 09-30-2020 10-Q
4 08-13-2020 06-30-2020 10-Q
5 05-14-2020 03-31-2020 10-Q
6 04-30-2020 12-31-2019 10-K
7 11-14-2019 09-30-2019 10-Q
8 08-19-2019 06-30-2019 10-Q
9 05-20-2019 03-31-2019 10-Q
10 05-16-2019 12-31-2018 10-K
11 11-14-2018 09-30-2018 10-Q
12 08-20-2018 06-30-2018 10-Q
13 05-15-2018 03-31-2018 10-Q
14 04-02-2018 12-31-2017 10-K
15 11-14-2017 09-30-2017 10-Q
16 08-08-2017 06-30-2017 10-Q
17 05-15-2017 03-31-2017 10-Q
18 03-08-2017 12-31-2016 10-K
19 11-14-2016 09-30-2016 10-Q
20 08-12-2016 06-30-2016 10-Q
21 05-10-2016 03-31-2016 10-Q
22 03-28-2016 12-31-2015 10-K
23 11-09-2015 09-30-2015 10-Q
24 08-07-2015 06-30-2015 10-Q
25 05-08-2015 03-31-2015 10-Q
26 03-13-2015 12-31-2014 10-K
27 11-12-2014 09-30-2014 10-Q
28 08-08-2014 06-30-2014 10-Q
29 05-13-2014 03-31-2014 10-Q
30 03-27-2014 12-31-2013 10-K
31 11-08-2013 09-30-2013 10-Q
32 08-08-2013 06-30-2013 10-Q
33 05-10-2013 03-31-2013 10-Q
34 03-07-2013 12-31-2012 10-K
35 11-08-2012 09-30-2012 10-Q
36 08-08-2012 06-30-2012 10-Q
37 05-10-2012 03-31-2012 10-Q
38 03-15-2012 12-31-2011 10-K
39 11-04-2011 09-30-2011 10-Q
40 08-05-2011 06-30-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
08/14/2025 23:50:04

reshape-lifesciences-q2-eps-225-up-from-8700-yoy-sales-1242m-down-from-1965m-yoy
Reshape Lifesciences Q2 EPS $(2.25) Up Fro...
08/14/2025 21:23:54

Reshape Lifesciences (NASDAQ:RSLS) reported quarterly losses of $(2.25) per share. This is a 97.41 percent increase over losses...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 17:06:22

vyome-therapeutics-to-begin-trading-as-vyome-holdings-inc-under-ticker-hind-on-nasdaq-effective-august-15-following-merger-with-reshape-lifesciences
Vyome Therapeutics To Begin Trading As Vyo...
08/13/2025 15:52:19

Effective as of Commencement of Trading on August 15, 2025Vyome Therapeutics, Inc., a clinical-stage healthcare company targeti...

vyome-therapeutics-sets-board-to-lead-reshape-lifesciences-post-close-new-entity-to-trade-as-vyome-holdings-under-ticker-symbol-hind
Vyome Therapeutics Sets Board To Lead Resh...
08/12/2025 13:55:53

Heavily shareholder-aligned board and management team completely replaces ReShape team as Vyome prepares for public listing on ...

reshape-lifesciences-received-approval-to-complete-vyome-therapeutics-merger
ReShape Lifesciences Received Approval To ...
08/07/2025 21:22:33

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
07/25/2025 21:06:49

reshape-lifesciences-granted-us-patent-related-to-an-intragastric-balloon-system
'ReShape Lifesciences Granted U.S. Patent ...
07/08/2025 14:26:49

https://reshapelifesciences.gcs-web.com/news-releases/news-release-details/reshape-lifesciencesr-granted-us-patent-related-intr...

reshape-lifesciences-granted-us-patent-12350179-entitled-intragastric-device
ReShape Lifesciences Granted U.S. Patent 1...
07/01/2025 12:34:56

The patent, related to the Company's application 18/241,151 and notice of allowance received in April, covers claims for an...

reshape-lifesciences-regains-nasdaq-compliance-under-minimum-stockholders-equity-requirement
ReShape Lifesciences Regains Nasdaq Compli...
06/27/2025 13:06:33

reshape-lifesciences-announces-strategic-headcount-reduction-issues-update-on-merger-agreement-with-vyome-therapeutics-and-asset-purchase-agreement-with-biorad-medisys
ReShape Lifesciences Announces Strategic H...
06/26/2025 12:33:54

Reduction in Force Estimated to Save Over $750K or 23.4% of Annual Payroll ExpensesAgreements Progress Toward Completion; Share...

reshape-lifesciences-granted-patent-in-australia-for-its-diabetes-neuromodulation-technology
ReShape Lifesciences Granted Patent In Aus...
06/25/2025 12:32:53

reshape-lifesciences-will-be-issued-us-patent-number-12329972-tomorrow-titled-high-frequency-low-duty-cycle-patterns-for-nerual-regulation-for-treatment-of-gi-conditions-including-obesity--other-eating-disorders-ibd-pancreatitis-diabetes-and-hypertension
ReShape Lifesciences Will Be Issued US Pat...
06/17/2025 00:08:58

why-rh-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why RH Shares Are Trading Higher By Around...
06/13/2025 09:08:07

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
06/12/2025 17:06:14

reshape-lifesciences-signs-exclusive-us-distribution-deal-with-recon-supply-to-expand-access-in-va-and-dod-healthcare-systems
ReShape Lifesciences Signs Exclusive U.S. ...
06/12/2025 12:55:38

ReShape Lifesciences® (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health solutions company, today announ...

crude-oil-moves-higher-graham-shares-surge-after-q4-results
Crude Oil Moves Higher; Graham Shares Surg...
06/09/2025 17:10:42

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/09/2025 17:06:06

us-stocks-mixed-motorcar-parts-of-america-posts-upbeat-earnings
US Stocks Mixed; Motorcar Parts of America...
06/09/2025 14:04:59

reshape-lifesciences-prices-26m-public-offering-of-1054604-shares-at-250-per-share
ReShape Lifesciences Prices $2.6M Public O...
06/09/2025 13:02:31

ReShape Lifesciences®("ReShape" or the "Company") (NASDAQ:RSLS), the premier physician-led weight loss and meta...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION